Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

New Horizon Health Signs Up Prenetics to Market Colorectal Test

publication date: Oct 22, 2019

New Horizon Health, a Beijing company that develops tests for early diagnosis of GI and lung cancers, will partner with Prenetics to market ColoClear, its non-invasive colorectal cancer tests in Hong Kong and Southeast Asia. Prenetics is a global genetic testing company that operates its direct-to-consumer genomics business via two subsidiaries -- CircleDNA in Asia and DNAFit in Europe. New Horizon, which developed ColoClear specifically for people of Asian ethnicity, says the test detected colon cancer with 92% sensitivity in clinical trials. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital